AFGAS
IRWD icon

Allegiance Financial Group Advisory Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Allegiance Financial Group Advisory Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.8K Buy
10,875
+158
+1% +$609 0.01% 204
2026
Q1 		$37.6K Buy
+10,717
New +$43.9K 0.01% 198
2025
Q4 		– Sell
-10,108
Closed -$13.2K – 188
2025
Q3 		$13.2K Buy
+10,108
New +$10.5K ﹤0.01% 164

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allegiance Financial Group Advisory Services's IRWD Position: Q2 2026 in Review

Allegiance Financial Group Advisory Services increased its Ironwood Pharmaceuticals (IRWD) stake by 1.5% in Q2 2026, buying an estimated $609 and bringing the position to 10,875 shares worth $45.8K. The position accounts for 0.01% of the portfolio, ranked #204.

Allegiance Financial Group Advisory Services first reported a position in IRWD in Q3 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Allegiance Financial Group Advisory Services held 10,875 shares of Ironwood Pharmaceuticals worth $45.8K as of Q2 2026.
  • Allegiance Financial Group Advisory Services bought 158 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $609.
  • Ironwood Pharmaceuticals made up 0.01% of Allegiance Financial Group Advisory Services's portfolio in Q2 2026, its #204 holding.
  • Allegiance Financial Group Advisory Services first reported a position in Ironwood Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Allegiance Financial Group Advisory Services's 13F filing for Q2 2026, filed 27 Jul 2026.